The trademark application EXECUPHARM was filed by Execupharm, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 23, 2022, and it was registered by office on January 30, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).